TheMiddleClassTrader

Cadila Healthcare

Long
NSE:CADILAHC   None
The stock has been hammered 27 percent from its high and is now at crucial support. The recent vaccine orders for 1 crore doses from Government India @265rs per dose might be beneficial to the company's stock price. Risk Reward Ratio is nearly 1.12.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.